The Global Times learned about Beijing’s distribution plans for Pfizer’s COVID-19 treatment drug Paxlovid from an online training session for doctors and nursing staff on how to advise patients to use the drug on Monday.
Beijing wants to help treat important populations as the city’s peak caseload approaches.
Pfizer’s Paxlovid
In accordance with the unified deployment, Nematavir/Ritonavir tablets Paxlovid will be distributed to all community health centers, and community doctors will advise COVID-19 patients in their areas to take anti-viral treatment, according to a document obtained by the Global Times on Monday from the Beijing Municipal Health Commission.
The Global Times reporter who attended Monday’s online training session discovered that the conference drew over 30,000 doctors and nursing staff from community health clinics and family physicians in the nation’s capital.
The drug reserve will be distributed to community health centers in proportion to the number of priority populations. Approximately 420,000 Beijing citizens are recognized as important populations.
People below the age of 80 with unstable underlying conditions, such as chronic renal disease, diabetes, cardiovascular disease, chronic lung disease, and coronary heart disease, as well as those over the age of 80 who have not been fully vaccinated.
Patients undergoing dialysis treatment, cancer patients undergoing pain chemotherapy, and older persons with disabilities are other crucial populations.
Read more: China COVID-19 update: New coronavirus variant circulates
Medication Still Not For Sale
China Meheco Corp. stated on Monday that the antiviral medication cannot be purchased online, despite a sharp increase in demand for Paxlovid.
In February 2022, China’s medical regulatory agency granted Pfizer’s therapy conditional approval. The medication is now covered by the country’s health insurance.
More than 20,000 cartons of Paxlovid were imported, as per media reports, and sent to COVID-19 treatment frontlines in at least eight Chinese provinces and municipalities, including Shanghai and Jilin Province.
The training program advised community health centers to use oxygen therapy as an early intervention method for seriously ill patients in a rational and scientific way.
Read more: COVID-19 vaccines caused millions of increased deaths in the US; Is this true?
